Medical research firm Recardio has halted clinical trials of its heart drug in the Clydebank , citing uncertainty over Brexit . The UK company was due to conduct trials of dutogliptin on patients in Clydebank , Exeter and Leeds , but has now suspended all its activities in the UK . A Scottish government spokesman said "this is the first clinical study we are aware of to be suspended in Scotland as a result of Brexit - and a very concerning sign of what could happen". the European Medicines Agency faces a "significant risk" from Jane-Claire Judson and "unresolved" issues with Recardio , the company reportedly wrote in an email to its research team. The position may change once the post- Brexit regulatory situation is clearer, it added.
Medical research firm Recardio has halted clinical trials of its heart drug in the Clydebank , citing uncertainty over Brexit . The UK company was due to conduct trials of dutogliptin on patients in Clydebank , Exeter and Leeds , but has now suspended all its activities in the UK . the European Medicines Agency faces a "significant risk" from Jane-Claire Judson and "unresolved" issues with Recardio , the company reportedly wrote in an email to its research team. The position may change once the post- Brexit regulatory situation is clearer, it added.